Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

Press releases

Gustave Roussy reaffirms its commitment to research integrity

On

Villejuif, 18 june 2019

Gustave Roussy reaffirms its commitment to research integrity

On Thursday 13 June, Prof. Eric Solary, Director of Research at Gustave Roussy, signed up to the French Charter for Research Integrity on behalf of the Institute, in the presence of Joëlle Alnot, Director of the French Office for Research Integrity (Ofis).

Ratifying this charter is a strong affirmation of Gustave Roussy’s dedication to the fundamental principles of research integrity, joining the large and growing number of public institutions engaged in higher education and research who have already signed up. Through its innovation, training and research work, Gustave Roussy aims to help consolidate the relationship of trust between the research community and society at large.

“This is a strong message from Gustave Roussy to all of the institute’s employees, to all other institutions combining care, research and training, and to the scientific community as a whole, in light of the challenges and stakes at play here,” enthuses Joëlle Alnot.

This new move represents a logical continuation of the proactive policy initiated in 2017, when Prof. Jean Feunteun was appointed as Gustave Roussy’s Research Integrity Officer. During the signing ceremony, Prof. Feunteun reiterated his conviction that, “while ethical matters will always be a open to debate, research integrity is not.”

The French Charter for Research Integrity [1] explicitly sets “the professional responsibilities ensuring a rigorous and trustworthy scientific approach, and will apply in the context of all national and international partnerships.” It is broken down into seven core principles:

  • compliance with legislative and regulatory requirements;
  • reliability of research work;
  • communication;
  • responsibility in collective work;
  • impartiality and independence in assessment and expertise;
  • collaborative work and plurality of activities;
  • training.

“Respect for research integrity is a constant priority at Gustave Roussy. Our signature of the national charter is an important part of our efforts to raise awareness of these issues and support our researchers and the students whom they teach and supervise. We remain totally committed to these principles, which apply to all forms of medical and scientific research conducted at the institute.” Professor Solary concluded.

[1] Available to download on the hceres.fr website

Gustave Roussy

Europe’s leading centre in the fight against cancer, Gustave Roussy is an institute dedicated to care, research and teaching. The institute treats patients suffering from all forms of the disease.

Adopting an integrated approach which combines research, care and teaching in the best interest of patients, Gustave Roussy bridges the gaps between fundamental, clinical and translational research.

The institute’s ambition is to keep pushing back the frontiers of science, reinventing cancer care and exploring all possible sources of innovation. Gustave Roussy is devoted to a high quality, less invasive and more personal approach to medicine, putting cutting-edge research, avant-garde technologies and innovative services to work in the interests of patients and their families.

Ofis

Founded in March 2017, the French Office for Research Integrity (OFIS) is a division of the French High Council for Evaluation of Research and Higher Education (Hcéres). OFIS is a national, interdisciplinary organisation with three key responsibilities:

  • expert guidance for institutions working to meet their obligations;
  • observation, supervision and sharing of best practices in research integrity;
  • helping to define and coordinate a national policy on research integrity.

The French Council for Research Integrity (CoFIS) is responsible for steering and supervising the work of Ofis.

Website: www.hceres.fr/fr/integrite-scientifique

▶

 

Press contact

If you are a journalist and have a question, please contact:

Claire Parisel or Léona Pinto
Tel. +33 1 42 11 50 59
Tel. +33 1 42 11 63 59
Mob. +33 6 17 66 00 26
Email

The Media Team cannot respond to patient inquiries.

Last press releases

  • Gold september: two new research programmes launched to tackle childhood cancers

    Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in the development of certain childhood cancers, as well as second cancers that may occur in adulthood. The second, INSPIRE, will draw on the knowledge and techniques already developed at the Institute to create organoids, with the aim of deciphering the mechanisms underlying metastasis and resistance to treatment.

    Photographie enfant pédiatrie
  • Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe

    By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026. At the helm of the Institute for five more years, Prof. Barlesi will continue the transformations undertaken during his first term. This renewal reflects the confidence placed in the project led by the institution to accelerate progress in the fight against cancer, foster and support the development of innovations set to change the future of oncology, and strengthen the influence of one of the world's leading cancer centers.

    Fabrice Barlesi
  • Route du Rhum 2026 Jean Le Cam and Christophe Rateau to sail for Gustave Roussy

    For the Route du Rhum - Destination Guadeloupe 2026, Jean Le Cam and Christophe Rateau will sail under the colors of Gustave Roussy, the leading cancer center in France and Europe. Competing respectively in the Vintage and Class40 categories, the two skippers will carry the Institute's mission to the general public, supporting cancer research and raising awareness of prevention, innovation and patient care.

    Jean Le Cam - Christophe Rateau
  • Owkin and Gustave Roussy partner to bring K Pro into real-world clinical practice

    Owkin and Gustave Roussy, Europe's leading cancer center, today announced a partnership to test K Pro directly within the hospital's real-world clinical and research workflows.